XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 10, 2024
Sep. 28, 2023
Mar. 07, 2023
Jan. 22, 2021
Jul. 21, 2020
Feb. 28, 2025
Nov. 30, 2024
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
May 31, 2024
May 31, 2023
Product Information [Line Items]                        
Accumulated deficit           $ 51,624,000     $ 51,624,000   $ 48,195,000  
Cash and cash equivalents           3,058,000     3,058,000   4,170,000  
Working capital           4,555,000     4,555,000      
Sale of stock, consideration received on transaction $ 5,500,000     $ 15,000,000 $ 90,000,000              
Proceeds from issuance of common stock                 2,143,000    
Average trading volume shares 7,798,345                      
Common stock issuance value   $ 20,000,000       1,448,000 $ 567,000          
Deferred offering costs $ 81,000                      
Revenues           1,119,000   $ 1,017,000 4,562,000 4,299,000    
Other receivables, gross, current           1,293,000     $ 1,293,000   966,000  
Threshold period past due for write-off of trade accounts receivable                 90 days      
Accounts receivable, credit loss expense (Reversal)           25,000     $ 25,000   19,000  
Prepaid expense and other assets           223,000     223,000   238,000  
Inventory reserves           422,000     422,000   467,000  
Amortization of intangible assets           5,000   4,000 14,000 13,000    
Intangible asset impairment charges                 0 0    
Investments           165,000     165,000   $ 165,000  
Share-based compensation related to stock options           91,000   340,000 323,000 633,000    
Share-based compensation expense related to RSU                 352,000 633,000    
Proceeds from customers                 55,000      
Research and development expense           217,000   343,000 771,000 1,226,000    
Advertising expense           4,000   25,000 30,000 80,000    
Foreign currency translation           0   0 $ 0 $ 0    
Stock issued during period shares restricted stock award net of forfeitures                 780,000 0    
Share-Based Payment Arrangement, Option [Member]                        
Product Information [Line Items]                        
Antidilutive securities excluded from computation of earnings per share, amount (in shares)                 3,343,866 3,506,616    
Restricted Stock Units (RSUs) [Member]                        
Product Information [Line Items]                        
Share-based compensation expense related to RSU           29,000   0 $ 29,000 $ 0    
Polish Distributor [Member]                        
Product Information [Line Items]                        
Investments           $ 165,000     $ 165,000      
Equity method investment, ownership percentage           6.00%     6.00%      
Marketing and Distribution Rights [Member]                        
Product Information [Line Items]                        
Finite-lived intangible asset, useful life           18 years     18 years      
Purchased Technology Rights [Member]                        
Product Information [Line Items]                        
Finite-lived intangible asset, useful life           10 years     10 years      
Patents [Member]                        
Product Information [Line Items]                        
Finite-lived intangible asset, useful life           15 years     15 years      
Property, Plant and Equipment [Member]                        
Product Information [Line Items]                        
Depreciation and amortization expense           $ 17,000   16,000 $ 50,000 46,000    
Asia [Member]                        
Product Information [Line Items]                        
Revenues           365,000   210,000 1,614,000 1,843,000    
North America [Member]                        
Product Information [Line Items]                        
Revenues           $ 404,000   $ 393,000 $ 1,381,000 $ 1,069,000    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Key Customers [Member] | United States Middle East And Asia [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage           61.00%            
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Key Customers [Member] | United States And Asia [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage               44.00%        
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Key Customers [Member] | Asia [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage                 35.00% 40.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Five Key Customers [Member] | North America [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage                 76.00%      
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Key Customers [Member] | Asia and Europe [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage                 64.00%      
Cost of Goods and Service, Product and Service Benchmark [Member] | Customer Concentration Risk [Member] | Two Key Vendors [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage                 33.00%   69.00%  
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Two Key Vendors [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage           39.00%            
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | One Key Vendors [Member]                        
Product Information [Line Items]                        
Concentration risk, percentage               50.00% 11.00% 18.00%    
Minimum [Member]                        
Product Information [Line Items]                        
Share price $ 0.27                      
Estimated useful lives           5 years     5 years      
Maximum [Member]                        
Product Information [Line Items]                        
Share price $ 1.03                      
Estimated useful lives           10 years     10 years      
2021 ATM Offering [Member]                        
Product Information [Line Items]                        
Sale of stock, consideration received on transaction                       $ 2,014,000
Sale of stock, number of shares issued in transaction                       573,889
Proceeds from issuance of common stock     $ 7,300,000                 $ 1,961,000
Sale of stock expenses     $ 700,000                 $ 53,000
Average trading volume shares     3,333,333                  
Share price     $ 2.40                  
2021 ATM Offering [Member] | Minimum [Member]                        
Product Information [Line Items]                        
Sale of stock, price per share                       $ 3.15
2021 ATM Offering [Member] | Maximum [Member]                        
Product Information [Line Items]                        
Sale of stock, price per share                       $ 4.26
May 2024 ATM Offering [Member]                        
Product Information [Line Items]                        
Sale of stock, consideration received on transaction                 $ 2,143,000      
Sale of stock, number of shares issued in transaction                 3,525,359      
Proceeds from issuance of common stock                 $ 2,015,000      
Sale of stock expenses                 $ 128,000      
May 2024 ATM Offering [Member] | Minimum [Member]                        
Product Information [Line Items]                        
Sale of stock, price per share           $ 0.36     $ 0.36      
May 2024 ATM Offering [Member] | Maximum [Member]                        
Product Information [Line Items]                        
Sale of stock, price per share           $ 1.04     $ 1.04